APA
Bourgeois-Daigneault M., Roy D. G., Aitken A. S., El Sayes N., Martin N. T., Varette O., Falls T., St-Germain L. E., Pelin A., Lichty B. D., Stojdl D. F., Ungerechts G., Diallo J. & Bell J. C. (20190304). Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy. : Science translational medicine.
Chicago
Bourgeois-Daigneault Marie-Claude, Roy Dominic Guy, Aitken Amelia Sadie, El Sayes Nader, Martin Nikolas Tim, Varette Oliver, Falls Theresa, St-Germain Lauren Elizabeth, Pelin Adrian, Lichty Brian Dennis, Stojdl David Francis, Ungerechts Guy, Diallo Jean-Simon and Bell John Cameron. 20190304. Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy. : Science translational medicine.
Harvard
Bourgeois-Daigneault M., Roy D. G., Aitken A. S., El Sayes N., Martin N. T., Varette O., Falls T., St-Germain L. E., Pelin A., Lichty B. D., Stojdl D. F., Ungerechts G., Diallo J. and Bell J. C. (20190304). Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy. : Science translational medicine.
MLA
Bourgeois-Daigneault Marie-Claude, Roy Dominic Guy, Aitken Amelia Sadie, El Sayes Nader, Martin Nikolas Tim, Varette Oliver, Falls Theresa, St-Germain Lauren Elizabeth, Pelin Adrian, Lichty Brian Dennis, Stojdl David Francis, Ungerechts Guy, Diallo Jean-Simon and Bell John Cameron. Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy. : Science translational medicine. 20190304.